CSL report earnings this morning and the market expects a 9% increase in sales and EDITDA

Chris Weston


CSL report earnings this morning and the market expects a 9% increase in sales and EDITDA. NPAT profit is expected to come out at $683 million, while the pharma giant is likely to detail a dividend of 55c. It's not cheap on 22x forward PE, however it hasn't been cheap for some time and traders have been happy to pay up for the growth. A good result, backed by guidance that is unchanged from its October update of 10% constant currency NPAT growth could see the stock look to test the recent high of A$71.20.

Chris Weston
Head of Research

Highly accomplished financial markets professional, with experience at a number of top-tier global institutions on both the buy and sell-side. A natural communicator with a strong ability to analyse macro-economic trends, capital flows and market...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

trending on livewire
Get the best of Livewire by signing up to our popular daily newsletter